カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

腸チフスVi多糖体ワクチンの世界市場2022：子供用、大人用

◆英語タイトル：Global Typhoid Vi Polysaccharide Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22DC3951）◆商品コード：GIR22DC3951
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2023年1月
◆ページ数：72
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

世界の腸チフスVi多糖体ワクチン市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界の腸チフスVi多糖体ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

腸チフスVi多糖体ワクチン市場はタイプとアプリケーションによって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・子供用、大人用

アプリケーション別セグメントは次のように区分されます。
・政府機関、民間、その他

世界の腸チフスVi多糖体ワクチン市場の主要な市場プレーヤーは以下のとおりです。
・Sanofi Pasteur SA、GSK

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、腸チフスVi多糖体ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な腸チフスVi多糖体ワクチンメーカーの企業概要、2019年～2022年までの腸チフスVi多糖体ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な腸チフスVi多糖体ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別腸チフスVi多糖体ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの腸チフスVi多糖体ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での腸チフスVi多糖体ワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および腸チフスVi多糖体ワクチンの産業チェーンを掲載しています。
・第13、14、15章では、腸チフスVi多糖体ワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– 腸チフスVi多糖体ワクチンの概要
– 種類別分析（2017年vs2021年vs2028年）：子供用、大人用
– 用途別分析（2017年vs2021年vs2028年）：政府機関、民間、その他
– 世界の腸チフスVi多糖体ワクチン市場規模・予測
– 世界の腸チフスVi多糖体ワクチン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Sanofi Pasteur SA、GSK
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：子供用、大人用
・用途別分析2017年-2028年：政府機関、民間、その他
・腸チフスVi多糖体ワクチンの北米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・腸チフスVi多糖体ワクチンのヨーロッパ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・腸チフスVi多糖体ワクチンのアジア市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・腸チフスVi多糖体ワクチンの南米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・腸チフスVi多糖体ワクチンの中東・アフリカ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

❖ レポートの目次 ❖

1 Market Overview
1.1 Typhoid Vi Polysaccharide Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Typhoid Vi Polysaccharide Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Child
1.2.3 Adult
1.3 Market Analysis by Application
1.3.1 Overview: Global Typhoid Vi Polysaccharide Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Global Typhoid Vi Polysaccharide Vaccine Market Size & Forecast
1.4.1 Global Typhoid Vi Polysaccharide Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Typhoid Vi Polysaccharide Vaccine Sales in Volume (2017-2028)
1.4.3 Global Typhoid Vi Polysaccharide Vaccine Price (2017-2028)
1.5 Global Typhoid Vi Polysaccharide Vaccine Production Capacity Analysis
1.5.1 Global Typhoid Vi Polysaccharide Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Typhoid Vi Polysaccharide Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Typhoid Vi Polysaccharide Vaccine Market Drivers
1.6.2 Typhoid Vi Polysaccharide Vaccine Market Restraints
1.6.3 Typhoid Vi Polysaccharide Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi Pasteur SA
2.1.1 Sanofi Pasteur SA Details
2.1.2 Sanofi Pasteur SA Major Business
2.1.3 Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Product and Services
2.1.4 Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Typhoid Vi Polysaccharide Vaccine Product and Services
2.2.4 GSK Typhoid Vi Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Typhoid Vi Polysaccharide Vaccine Breakdown Data by Manufacturer
3.1 Global Typhoid Vi Polysaccharide Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Typhoid Vi Polysaccharide Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Typhoid Vi Polysaccharide Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Typhoid Vi Polysaccharide Vaccine Manufacturer Market Share in 2021
3.5 Global Typhoid Vi Polysaccharide Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Typhoid Vi Polysaccharide Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Typhoid Vi Polysaccharide Vaccine Market Size by Region
4.1.1 Global Typhoid Vi Polysaccharide Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Region (2017-2028)
4.2 North America Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028)
4.3 Europe Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028)
4.5 South America Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Typhoid Vi Polysaccharide Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Type (2017-2028)
5.3 Global Typhoid Vi Polysaccharide Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Typhoid Vi Polysaccharide Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Application (2017-2028)
6.3 Global Typhoid Vi Polysaccharide Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Typhoid Vi Polysaccharide Vaccine Sales by Type (2017-2028)
7.2 North America Typhoid Vi Polysaccharide Vaccine Sales by Application (2017-2028)
7.3 North America Typhoid Vi Polysaccharide Vaccine Market Size by Country
7.3.1 North America Typhoid Vi Polysaccharide Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Typhoid Vi Polysaccharide Vaccine Sales by Type (2017-2028)
8.2 Europe Typhoid Vi Polysaccharide Vaccine Sales by Application (2017-2028)
8.3 Europe Typhoid Vi Polysaccharide Vaccine Market Size by Country
8.3.1 Europe Typhoid Vi Polysaccharide Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Typhoid Vi Polysaccharide Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market Size by Region
9.3.1 Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Typhoid Vi Polysaccharide Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Typhoid Vi Polysaccharide Vaccine Sales by Type (2017-2028)
10.2 South America Typhoid Vi Polysaccharide Vaccine Sales by Application (2017-2028)
10.3 South America Typhoid Vi Polysaccharide Vaccine Market Size by Country
10.3.1 South America Typhoid Vi Polysaccharide Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Typhoid Vi Polysaccharide Vaccine Market Size by Country
11.3.1 Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Typhoid Vi Polysaccharide Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Typhoid Vi Polysaccharide Vaccine
12.3 Typhoid Vi Polysaccharide Vaccine Production Process
12.4 Typhoid Vi Polysaccharide Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Typhoid Vi Polysaccharide Vaccine Typical Distributors
13.3 Typhoid Vi Polysaccharide Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Typhoid Vi Polysaccharide Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Typhoid Vi Polysaccharide Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Sanofi Pasteur SA Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur SA Major Business
Table 5. Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Product and Services
Table 6. Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Typhoid Vi Polysaccharide Vaccine Product and Services
Table 10. GSK Typhoid Vi Polysaccharide Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Global Typhoid Vi Polysaccharide Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 12. Global Typhoid Vi Polysaccharide Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 13. Market Position of Manufacturers in Typhoid Vi Polysaccharide Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 14. Global Typhoid Vi Polysaccharide Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 15. Head Office and Typhoid Vi Polysaccharide Vaccine Production Site of Key Manufacturer
Table 16. Typhoid Vi Polysaccharide Vaccine New Entrant and Capacity Expansion Plans
Table 17. Typhoid Vi Polysaccharide Vaccine Mergers & Acquisitions in the Past Five Years
Table 18. Global Typhoid Vi Polysaccharide Vaccine Sales by Region (2017-2022) & (K Units)
Table 19. Global Typhoid Vi Polysaccharide Vaccine Sales by Region (2023-2028) & (K Units)
Table 20. Global Typhoid Vi Polysaccharide Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 21. Global Typhoid Vi Polysaccharide Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 22. Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 23. Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2023-2028) & (K Units)
Table 24. Global Typhoid Vi Polysaccharide Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 25. Global Typhoid Vi Polysaccharide Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 26. Global Typhoid Vi Polysaccharide Vaccine Price by Type (2017-2022) & (USD/Unit)
Table 27. Global Typhoid Vi Polysaccharide Vaccine Price by Type (2023-2028) & (USD/Unit)
Table 28. Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
Table 29. Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2023-2028) & (K Units)
Table 30. Global Typhoid Vi Polysaccharide Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 31. Global Typhoid Vi Polysaccharide Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 32. Global Typhoid Vi Polysaccharide Vaccine Price by Application (2017-2022) & (USD/Unit)
Table 33. Global Typhoid Vi Polysaccharide Vaccine Price by Application (2023-2028) & (USD/Unit)
Table 34. North America Typhoid Vi Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
Table 35. North America Typhoid Vi Polysaccharide Vaccine Sales by Country (2023-2028) & (K Units)
Table 36. North America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 37. North America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 38. North America Typhoid Vi Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 39. North America Typhoid Vi Polysaccharide Vaccine Sales by Type (2023-2028) & (K Units)
Table 40. North America Typhoid Vi Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
Table 41. North America Typhoid Vi Polysaccharide Vaccine Sales by Application (2023-2028) & (K Units)
Table 42. Europe Typhoid Vi Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
Table 43. Europe Typhoid Vi Polysaccharide Vaccine Sales by Country (2023-2028) & (K Units)
Table 44. Europe Typhoid Vi Polysaccharide Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 45. Europe Typhoid Vi Polysaccharide Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 46. Europe Typhoid Vi Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 47. Europe Typhoid Vi Polysaccharide Vaccine Sales by Type (2023-2028) & (K Units)
Table 48. Europe Typhoid Vi Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
Table 49. Europe Typhoid Vi Polysaccharide Vaccine Sales by Application (2023-2028) & (K Units)
Table 50. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales by Region (2017-2022) & (K Units)
Table 51. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales by Region (2023-2028) & (K Units)
Table 52. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 53. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 54. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 55. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales by Type (2023-2028) & (K Units)
Table 56. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
Table 57. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales by Application (2023-2028) & (K Units)
Table 58. South America Typhoid Vi Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
Table 59. South America Typhoid Vi Polysaccharide Vaccine Sales by Country (2023-2028) & (K Units)
Table 60. South America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 61. South America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 62. South America Typhoid Vi Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 63. South America Typhoid Vi Polysaccharide Vaccine Sales by Type (2023-2028) & (K Units)
Table 64. South America Typhoid Vi Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
Table 65. South America Typhoid Vi Polysaccharide Vaccine Sales by Application (2023-2028) & (K Units)
Table 66. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Region (2017-2022) & (K Units)
Table 67. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Region (2023-2028) & (K Units)
Table 68. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 69. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 70. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 71. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Type (2023-2028) & (K Units)
Table 72. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
Table 73. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales by Application (2023-2028) & (K Units)
Table 74. Typhoid Vi Polysaccharide Vaccine Raw Material
Table 75. Key Manufacturers of Typhoid Vi Polysaccharide Vaccine Raw Materials
Table 76. Direct Channel Pros & Cons
Table 77. Indirect Channel Pros & Cons
Table 78. Typhoid Vi Polysaccharide Vaccine Typical Distributors
Table 79. Typhoid Vi Polysaccharide Vaccine Typical Customers
List of Figures
Figure 1. Typhoid Vi Polysaccharide Vaccine Picture
Figure 2. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type in 2021
Figure 3. Child
Figure 4. Adult
Figure 5. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application in 2021
Figure 6. Government Institution
Figure 7. Private Sector
Figure 8. Other
Figure 9. Global Typhoid Vi Polysaccharide Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Typhoid Vi Polysaccharide Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Typhoid Vi Polysaccharide Vaccine Sales (2017-2028) & (K Units)
Figure 12. Global Typhoid Vi Polysaccharide Vaccine Price (2017-2028) & (USD/Unit)
Figure 13. Global Typhoid Vi Polysaccharide Vaccine Production Capacity (2017-2028) & (K Units)
Figure 14. Global Typhoid Vi Polysaccharide Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Typhoid Vi Polysaccharide Vaccine Market Drivers
Figure 16. Typhoid Vi Polysaccharide Vaccine Market Restraints
Figure 17. Typhoid Vi Polysaccharide Vaccine Market Trends
Figure 18. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Manufacturer in 2021
Figure 19. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Manufacturer in 2021
Figure 20. Typhoid Vi Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Typhoid Vi Polysaccharide Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Typhoid Vi Polysaccharide Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Region (2017-2028)
Figure 24. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Region (2017-2028)
Figure 25. North America Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Europe Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. South America Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (USD Million)
Figure 30. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
Figure 31. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)
Figure 32. Global Typhoid Vi Polysaccharide Vaccine Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
Figure 34. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application (2017-2028)
Figure 35. Global Typhoid Vi Polysaccharide Vaccine Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
Figure 37. North America Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
Figure 38. North America Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2017-2028)
Figure 39. North America Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country (2017-2028)
Figure 40. United States Typhoid Vi Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Typhoid Vi Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Typhoid Vi Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
Figure 44. Europe Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
Figure 45. Europe Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2017-2028)
Figure 46. Europe Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country (2017-2028)
Figure 47. Germany Typhoid Vi Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Typhoid Vi Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Typhoid Vi Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Typhoid Vi Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Typhoid Vi Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Region (2017-2028)
Figure 56. China Typhoid Vi Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Typhoid Vi Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Typhoid Vi Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Typhoid Vi Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Typhoid Vi Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Typhoid Vi Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
Figure 63. South America Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
Figure 64. South America Typhoid Vi Polysaccharide Vaccine Sales Market Share by Country (2017-2028)
Figure 65. South America Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Typhoid Vi Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Typhoid Vi Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Typhoid Vi Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Typhoid Vi Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Typhoid Vi Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Typhoid Vi Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Typhoid Vi Polysaccharide Vaccine in 2021
Figure 77. Manufacturing Process Analysis of Typhoid Vi Polysaccharide Vaccine
Figure 78. Typhoid Vi Polysaccharide Vaccine Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 腸チフスVi多糖体ワクチンの世界市場2022：子供用、大人用(Global Typhoid Vi Polysaccharide Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 10価肺炎球菌多糖体ワクチンの世界市場2022：単回投与バイアル、プレフィルドシリンジ
  • 世界の腸チフス経口ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 10価肺炎球菌結合型ワクチンの世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆